KCT0006828
Not yet recruiting
未知
Effective Dose of Remimazolam for Sedation in Patients Undergoing Lower Extremity Surgery under Spinal Anesthesia
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the musculoskeletal system and connective tissue
- Sponsor
- Asan Medical Center
- Enrollment
- 50
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\*Age: Adults aged 19 to 65
- •\*Patients with ASA PS 1\-3
- •\*Patients receiving sedation using remimazolam among patients undergoing lower extremity surgery under spinal anesthesia
Exclusion Criteria
- •\*Patients who refused to participate in the study
- •\* Patients with hypersensitivity to benzodiazepines or flumazenil
- •\*Patients with severe liver disease
- •\*Patients with communication difficulties
- •\*Patients with severe obstructive sleep apnea or other diseases expected to difficult airway
- •\*Patients who are contraindicated in spinal anesthesia
- •\*Patients who are judged unsuitable for participation by medical staff for other reasons
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Optimal Dose of Remimazolam for Sedation During Spinal Anesthesia in Age 60+: A Preliminary StudyDiseases of the musculoskeletal system and connective tissueKCT0007075Korea University Anam Hospital20
Recruiting
Not Applicable
Efficacy of administering remimazolam at anesthetic management for awake craniotomyJPRN-jRCT1041200094ishiwaki Kimitoshi58
Completed
Not Applicable
The examination of sedation depth of remimazolam in general anesthesia: Pilot studythe patients of breast tumorJPRN-UMIN000042085kyushu university hospital40
Completed
Not Applicable
Remimazolam during induction of anesthesia in patients with severe aortic stenosisSevere aortic stenosisJPRN-UMIN000042318agoya City University Graduate School of Medical Sciences, Department of Anesthesiology and Intensive Care Medicine20
Unknown
Not Applicable
The 90% Effective Sedation Dose Of MidazolamGastro-Esophageal Reflux Disease With UlcerationNCT03813043King Fahad Specialist Hospital Dammam40